These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2527373)

  • 1. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
    Smith EF; Egan JW; Griswold DE
    Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.
    Smith EF; Nichols AJ; Sellers TS; O'Brien SR; Griswold DE; Egan JW; Hillegass LM; Vasko JA; Slivjak MJ; Davis PA
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):729-38. PubMed ID: 1723770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
    J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat.
    Smith EF; Egan JW; Goodman FR; Zimmerman MB; Webb RL; Ribeiro LG
    Pharmacology; 1988; 37(4):254-63. PubMed ID: 2973611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
    Leor J; Varda-Bloom N; Hasdai D; Ovadia Z; Battler A
    Angiology; 1994 Aug; 45(8):717-24. PubMed ID: 8048781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion.
    Oh BH; Ono S; Rockman HA; Ross J
    Circulation; 1993 Feb; 87(2):598-607. PubMed ID: 8425304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple technique for occlusion and reperfusion of coronary artery in conscious rats.
    Himori N; Matsuura A
    Am J Physiol; 1989 Jun; 256(6 Pt 2):H1719-25. PubMed ID: 2735441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the rat.
    Campo GM; Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Pollicino AM; Rizzo A; Calapai G; Calandra S; Scuri R
    Pharmacology; 1994 Mar; 48(3):157-66. PubMed ID: 8153143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered left ventricular remodeling with beta-adrenergic blockade and exercise after coronary reperfusion in rats.
    Oh BH; Ono S; Gilpin E; Ross J
    Circulation; 1993 Feb; 87(2):608-16. PubMed ID: 8093867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning.
    Verdouw PD; Gho BC; Koning MM; Schoemaker RG; Duncker DJ
    Ann N Y Acad Sci; 1996 Sep; 793():27-42. PubMed ID: 8906153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size.
    Kapur NK; Paruchuri V; Urbano-Morales JA; Mackey EE; Daly GH; Qiao X; Pandian N; Perides G; Karas RH
    Circulation; 2013 Jul; 128(4):328-36. PubMed ID: 23766351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
    Yamamoto H; Avkiran M
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556.
    Altavilla D; Squadrito F; Campo GM; Saitta A; Squadrito G; Quartarone C; Deodato B; Arlotta M; Ferlito M; Minutoli L; Tringali M; Urna G; Sardella A; Caputi AP
    Life Sci; 2000 Oct; 67(21):2615-29. PubMed ID: 11104363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction.
    Azizi Y; Faghihi M; Imani A; Roghani M; Nazari A
    Peptides; 2013 Aug; 46():76-82. PubMed ID: 23727032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion.
    Hock CE; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):285-94. PubMed ID: 3755540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.